Print

FDA Rejects Merck & Co., Inc. (MRK)'s Insomnia Drug  
7/1/2013 7:08:13 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Merck & Co Inc said the U.S. Food and Drug Administration rejected the company's experimental insomnia drug, citing safety issues.

In a complete response letter to the company, the FDA said the safety data of the drug do not support approval, and advised that lower doses of the medicine should be made available before an approval.

Help employers find you! Check out all the jobs and post your resume.

//-->